COVID-19 Vaccine


Vaccines are widely available across the country, and we understand you may have questions. Here’s what you need to know.

Image Image

What To Know About the COVID-19 Vaccine:

  • All U.S. residents age 5 and older are now eligible for the vaccine. Children ages 5 to 17 are eligible for the Pfizer vaccine and booster.
  • Find a COVID-19 vaccine or booster near you at vaccines.gov.
  • You won’t have any out-of-pocket costs for the vaccine.
  • The FDA and CDC consider COVID-19 vaccines safe and effective.
  • According to the CDC, you still need the vaccine even if you’ve had COVID-19 and you won’t get COVID-19 from a vaccine.
  • As of May 2022, the FDA recommends that distribution of the Johnson & Johnson vaccine be limited to individuals 18 years of age and older are unable to receive Moderna or Pfizer vaccines, or who specifically request the Johnson & Johnson vaccine, due to the ongoing risk of rare but serious blood clots.

    Additional Doses and Boosters:

    • Boosters and additional vaccine doses aren’t the same, and the recommendations for COVID-19 vaccines are different at this time.
    • Boosters are recommended for all adults age 18 and older. The Pfizer vaccine is authorized for children age 5 and older. See the chart below for more information.
    • As of March 2022, adults age 50 and older and certain people who are immunocompromised are eligible for a second booster dose of the Pfizer-BioNTech and the Moderna COVID-19 vaccines.

    COVID-19 Treatment:

    • The FDA has authorized Pfizer's antiviral COVID-19 treatment pill for high-risk patients age 12 years and older. Learn more here.

    COVID-19 Vaccine FAQs.
    We’ve compiled answers to your most-asked questions about COVID-19 vaccines.

    Read More

    COVID-19 Vaccine FAQs.
    We’ve compiled answers to your most-asked questions about COVID-19 vaccines.

    Current Vaccine Phases in Tennessee

    Image

    PHASE 1

    1 A1

    • Inpatient and other high-exposure health care workers
    • Residents and staff of long-term care facilities
    • First responders
    • Adults who cannot live independently

    1 A2

    • Outpatient health care workers with direct patient exposure, including mortuary services

    1 B

    • K-12 and child care staff
    • First responder operations personnel

    1 C

    • Those with high-risk health conditions including pregnancy
    • Caregivers of children with high-risk health conditions
    • Permanent household members age 16 and older living with pregnant women
    Image

    PHASE 2

    2 A

    Critical infrastructure, including:

    • Social services
    • Commercial agriculture
    • Commercial food production
    • Corrections staff
    • Public transit

    2 B

    Critical infrastructure, including:

    • Transportation
    • Public infrastructure
    • Telecommunications
    • Utilities/energy
    Image Image

    PHASE 3

    • Congregate living facilities, including corrections
    • Grocery workers
    • Everyone else who did not fall under a previous phase

    Image

    AGE-BASED

    In addition to the prioritized phases, Tennesseans are eligible for vaccines based on age. This timeline is tentative and is subject to change:

    • December 2020: Ages 75+
    • January/February 2021: Ages 70+
    • February 2021: 65+
    • March 2021: Ages 55+
    • April 5, 2021: Ages 16+

    Vaccine Phases in Tennessee

    Image

    PHASE 1

    1 A1

    • Inpatient and other high-exposure health care workers
    • Residents and staff of long-term care facilities
    • First responders
    • Adults who cannot live independently

    1 A2

    • Outpatient health care workers with direct patient exposure, including mortuary services

    1 B

    • K-12 and child care staff
    • First responder operations personnel

    1 C

    • Those with high-risk health conditions including pregnancy
    • Caregivers of children with high-risk health conditions
    • Permanent household members age 16 and older living with pregnant women
    Image

    PHASE 2

    2 A

    Critical infrastructure, including:

    • Social services
    • Commercial agriculture
    • Commercial food production
    • Corrections staff
    • Public transit

    2 B

    Critical infrastructure, including:

    • Transportation
    • Public infrastructure
    • Telecommunications
    • Utilities/energy
    Image Image

    PHASE 3

    • Congregate living facilities, including corrections
    • Grocery workers
    • Everyone else who did not fall under a previous phase
        Image

        AGE-BASED

        In addition to the prioritized phases, Tennesseans are eligible for vaccines based on age. This timeline is tentative and is subject to change:

        • December 2020: Ages 75+
        • January/February 2021: Ages 70+
        • February 2021: 65+
        • March 2021: Ages 55+
        • April 5, 2021: Ages 16+

        The Three COVID-19 Vaccines

        This chart, compiled from CDC and vaccine manufacturer data, helps explain the differences among the vaccines. It’s important to get vaccinated as soon as possible.

        As of Oct. 21, 2021, both the CDC and FDA have advised that any of the three authorized vaccines could be used as a booster in a “mix and match” approach for those who need additional protection. Boosters are for fully vaccinated people whose immune systems already built an appropriate level of protection. However, over time, this protection may need to be boosted again. You can find more information here.

        If you are immunocompromised, you may qualify for an additional vaccine dose. Read more here.


        Moderna

        Pfizer

        Johnson & Johnson JansSen

        • Under distribution
        • Under distribution
        • Under distribution
        • 2+ shots
        • 2+ shots
        • 1+ shot
        • 94.1% effective against positive COVID-19 test results or symptomatic infection
        • 95% effective against positive COVID-19 test results or symptomatic infection
        • 72% effective against COVID-19-related moderate to severe illness and 85% against severe cases
        • For ages 18+
        • Additional dose eligible for:
          • All adults ages 18+
        • For ages 5+
        • Additional dose eligible for:
          • Ages 5+
        • For ages 18+
        • Additional dose eligible for:
          • All adults ages 18+
        • Doses are 28 days apart
        • Booster 5 months after second dose
          • Adults ages 50+ and certain people who are immunocompromised are eligible for a second booster 4 months after getting their first booster.
        • Doses are 21 days apart
        • Booster 5 months after second dose
          • Adults ages 50+ and certain people who are immunocompromised are eligible for a second booster 4 months after getting their first booster.
        • 1 dose
        • Booster 2 months after original dose
        • Side effects may include fatigue, muscle pain, sore arm and rarely severe allergic reaction
        • Side effects may include fatigue, muscle pain, sore arm and rarely severe allergic reaction
        • Side effects may include fatigue, muscle pain and a sore arm
        • FDA-approved for people age 18 and older.
        • FDA-approved for people age 16 and older. FDA emergency use authorization for those 5 to 15 years old.
        • FDA emergency use authorization for people age 18 or older who are unable to receive Moderna or Pfizer, or upon specific request.

        Moderna

        • Under distribution
        • 2+ shots
        • 94.1% effective against positive COVID-19 test results or symptomatic infection
        • For ages 18+
        • Additional dose eligible for:
          • All adults ages 18+
        • Doses are 28 days apart
        • Booster 5 months after second dose
          • Adults ages 50+ and certain people who are immunocompromised are eligible for a second booster 4 months after getting their first booster.
        • Side effects may include fatigue, muscle pain, sore arm and rarely severe allergic reaction
        • FDA-approved for people age 18 and older.

        Pfizer

        • Under distribution
        • 2+ shots
        • 95% effective against positive COVID-19 test results or symptomatic infection
        • For ages 5+
        • Additional dose eligible for:
          • Ages 5+
        • Doses are 21 days apart
        • Booster 5 months after second dose
          • Adults ages 50+ and certain people who are immunocompromised are eligible for a second booster 4 months after getting their first booster.
        • Side effects may include fatigue, muscle pain, sore arm and rarely severe allergic reaction
        • FDA-approved for people age 16 and older. FDA emergency use authorization for those 5 to 15 years old.

        Johnson & Johnson JansSen

        • Under distribution
        • 1+ shot
        • 72% effective against COVID-19-related moderate to severe illness and 85% against severe cases
        • For ages 18+
        • Additional dose eligible for:
          • All adults ages 18+
        • 1 dose
        • Booster 2 months after original dose
        • Side effects may include fatigue, muscle pain and a sore arm
        • FDA emergency use authorization for people age 18 or older who are unable to receive Moderna or Pfizer, or upon specific request.

        It’s important to remember this information could change. We’ll update this page as researchers learn more.
        Image

        Guidelines after vaccination
        The CDC released recommendations for safely gathering once vaccinated against COVID-19.

        Image

        Guidelines after vaccination
        The CDC released recommendations for safely gathering once vaccinated against COVID-19.

        Learn More

        COVID-19 Vaccine FAQ ¿Habla Español?


        Are you a BlueCare Tennessee provider? Click here for information about COVID-19 vaccines.

        All other providers can find more information about COVID-19 vaccines here.

        We’ve compiled answers to your most-asked questions about COVID-19 vaccines. This is a developing situation, so check back for updated information.

        Preguntas frecuentes para miembros, sobre la vacuna contra el COVID-19